Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

489.800
+52.80012.08%
Volume:83.35K
Turnover:39.48M
Market Cap:43.53B
PE:-583.77
High:504.000
Open:437.000
Low:415.600
Close:437.000
52wk High:765.500
52wk Low:178.000
Shares:88.88M
HK Float Shares:88.88M
Volume Ratio:0.98
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.839
ROE:-39.50%
ROA:-23.53%
PB:48.22
PE(LYR):-583.77
PS:203.88

Loading ...

医疗AI龙头午盘飙升逾9%,券商首予买入评级看好三年十倍增长

Deep News
·
Aug 28

HK Stocks in Focus: DIAGENS-B Surges Nearly 9% in Morning Trade Following Inclusion in 23 Hang Seng Indexes

Stock News
·
Aug 28

Hong Kong Stocks Close: Hang Seng Falls 1.89% as Optical Communication Stocks Plunge, Alibaba Drops 8% on $10.2B AI-Focused Share Placement

Stock News
·
Aug 24

DIAGENS-B Surges Over 29% to Record High on Dual Index Inclusion

Deep News
·
Aug 24

Diagens-B Set to Join Multiple Hang Seng Index Constituent Lists

Stock News
·
Aug 24

Hangzhou Diagens Joins Hang Seng Composite Index Constituents from Sept. 7, 2026

Reuters
·
Aug 24

Dual Index Inclusion: DIAGENS-B (02526) Added to Both Hang Seng Composite and Hang Seng Biotechnology Indices, Unlocking Significant Valuation Upside

Stock News
·
Aug 22

AI-Driven Cancer Vaccine Success Propels DIAGENS-B to Record High, Index Inclusion on the Horizon

Deep News
·
Aug 21

Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again

Stock News
·
Aug 20

Diagens-B Surges Over 21% in Morning Trade as Model Service Revenue Soars 101.1% in First Half

Deep News
·
Aug 20

Diagens Tech (02526.hk): Model‑as‑a‑Service Revenue Surges 101.1% Year‑Over‑Year; Commercial Rollout of Its Medical Imaging AI Platform Gathers Momentum

THOMSON REUTERS
·
Aug 11

From Functional to Commercial: DIAGENS-B (02526) Interim Results Signal a Platform Value Reassessment for Medical AI

Stock News
·
Aug 10

Diagens Biotechnology's H1 Loss Widens

MT Newswires Live
·
Aug 07

Diagens Reports 1H26 Revenue Up 21% to RMB108.69 Million; Model Services Double, Net Loss Expands on Higher R&D Spend

Bulletin Express
·
Aug 07

Hangzhou Diagens FY26 H1 Loss Widens to RMB 55.88 Million; Revenue Rises 21% to RMB 108.69 Million

Reuters
·
Aug 07

Diagens Maintains Stable Share Base and Public Float Compliance in July 2026

Bulletin Express
·
Aug 03

DIAGENS-B Surges Over 13% in Morning Trading as Medical AI Innovation Ecosystem Takes Shape

Stock News
·
Aug 03

Earning Preview: DIAGENS-B this quarter’s revenue is expected to increase by 20%, and institutional views are bullish

Earnings Agent
·
Aug 01

Hong Kong Stock Market Moves | DIAGENS-B Rises Over 10% in Afternoon Session Following Platform Launch and Partnership Deals

Stock News
·
Jul 30

DIAGENS-B to Convene Board Meeting on 7 Aug 2026 for Interim Results and Dividend Deliberation

Bulletin Express
·
Jul 28